HEJDUK, Karel, Petr BRABEC, Zbyněk BORTLÍČEK and Daniel KLIMEŠ. RENIS - Votrient: stav registru k datu 7. 10. 2013 (RENIS - Votrient: state of the registry as of 7/10/2013). Brno: neuveden, 2013, 37 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name RENIS - Votrient: stav registru k datu 7. 10. 2013
Name (in English) RENIS - Votrient: state of the registry as of 7/10/2013
Authors HEJDUK, Karel (203 Czech Republic, belonging to the institution), Petr BRABEC (203 Czech Republic, guarantor, belonging to the institution), Zbyněk BORTLÍČEK (203 Czech Republic, belonging to the institution) and Daniel KLIMEŠ (203 Czech Republic, belonging to the institution).
Edition Brno, 37 pp. 2013.
Publisher neuveden
Other information
Original language Czech
Type of outcome Research report
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/13:00073119
Organization unit Faculty of Medicine
Keywords in English renal cell carcinoma; clinical registry
Changed by Changed by: Mgr. Jakub Gregor, Ph.D., učo 16577. Changed: 28/4/2014 21:28.
Abstract
Registr RenIS je neintervenční poregistrační databáze, zaměřená na sběr epidemiologických a klinických dat pacientů s karcinomem ledvin léčených cílenou léčbou v České republice. Zpráva přináší aktuální analýzu pacientů s karcinomem ledvin léčených pazopanibem.
Abstract (in English)
The RenIS registry is a non-interventional post-registration database focused on collection of epidemiological and clinical data of patients with renal cell carcinoma treated with targeted therapies in the Czech Republic. The report brings recent analysis of renal cell carcinoma patients treated with pazopanib.
PrintDisplayed: 27/7/2024 20:20